Jeffrey W Sherman Xeris Biopharma Holdings, Inc. (XERS) insider trading activity

Jeffrey W Sherman is Director of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 164,380 shares of XERS, which is worth approximately $471,770. The most recent transaction as insider was on Jun 05, 2024, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 164K

0% 3M change

52.38% 12M change

Total Value Held $471,770

JEFFREY W SHERMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2024	BUY Grant, award, or other acquisition	-	50,000 Added 23.32%	164,380 Common Stock
Mar 15 2024	BUY Other acquisition or disposition	-	6,502 Added 5.38%	114,380 Common Stock
Jun 07 2023	BUY Grant, award, or other acquisition	-	42,500 Added 28.26%	107,878 Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	-	15,000 Added 18.66%	65,378 Common Stock
Oct 05 2021	BUY Grant, award, or other acquisition	-	50,378 Added 50.0%	50,378 Common Stock

Also insider at

HZNP

Horizon Therapeutics Public Ltd Co Healthcare

EVP and Chief Medical Officer

SBBP

Strongbridge Biopharma plc

Director

XERS

XERIS PHARMACEUTICALS INC Healthcare

Director

LRMR

Larimar Therapeutics, Inc. Healthcare

Director

JWS